ImmuCell Corporation (ICCC) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

ImmuCell Corporation (ICCC) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $96.2M, listed on NASDAQ, employing roughly 69 people, carrying a beta of 0.50 to the broader market. ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. Led by F. Olivier Te Boekhorst, public since 1987-05-05.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for ICCC as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →